Gabapentin and Memantine for Treatment of Acquired Pendular Nystagmus: Effects on Visual Outcomes
Conclusions:
This study demonstrated that both memantine and gabapentin reduce APN, improving functional visual outcomes. Gabapentin showed a better tolerability, suggesting that this agent should be used as a first-line agent for APN. Data from our investigation emphasize the importance of visual functional outcome evaluations in clinical trials for APN.
Source: Journal of Neuro-Ophthalmology - Category: Opthalmology Tags: Original Contribution Source Type: research
More News: Brain | Clinical Trials | Eyes | Gabapentin | Multiple Sclerosis | Namenda | Neurology | Neurontin | Opthalmology | Study